Copy Link Print Information

Rosiglitazone potassium

(Synonyms: BRL 49653 potassium)
186 Cited Publications
Revisión del cliente

Based on 186 publication(s) in Google Scholar

Rosiglitazone (BRL 49653) potassium is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone potassium is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone potassium can be used in the research of obesity and diabetes, senescence, ovarian cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.13%
  • No. CAS: 316371-84-3
  • Fòrmula: C18H18KN3O3S
  • Peso molecular:395.52
  • Almacenamiento:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Rosiglitazone potassium Chemical Structure
    Rosiglitazone potassium Chemical Structure
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
  • Experimental Validation Results for Rosiglitazone potassium
No. CAS: 316371-84-3
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Rosiglitazone potassium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Rosiglitazone potassium

More
Customer Validation & Images
WBRT-PCRIFCell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • RT-PCR
  • WB
  • Cell Proliferation/Viability Assay
  • WB
  • WB
  • WB
  • IF
  • IF
  • WB

Ver todos los productos específicos de isoformas PPAR

More

Ver todos los productos específicos de isoformas TRP Channel

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Rosiglitazone potassium Chemical Structure
    Rosiglitazone potassium Chemical Structure
    1/16
  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Sep 10;16(1):8215. [Abstract]

    Customer Validation
     NECTIN4 mRNA levels in RT112 cells treated with 1μM Rosiglitazone and T0070907 (T007) for 72 h.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Nov 7;35(11):1915-1930.e8. [Abstract]

    Customer Validation
     C3H10T1/2 preadipocytes were treated with differentiation medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nM Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days and subsequently cultured in maintaining medium supplemented with 1 nM Triiodothyronine, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were cultured in complete medium until used for experiments. Representative immunoblots of PGC-1α and UCP1 in beige adipocytes treated as indicated.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Dec 5;35(12):2165-2182.e7. [Abstract]

    Customer Validation
     Relative GDF15 mRNA expression and GDF15 release in human primary hepatocytes treated with 10 μM rosiglitazone for 48 h.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Jun 2;14(1):3208. [Abstract]

    Customer Validation
     C3H10T1/2 preadipocytes were cultured in DMEM supplemented with 10% FBS, 1% P/S. For adipogenic differentiation, confluent C3H10T1/2 preadipocytes were incubated with complete medium supplemented with 0.5 mM 3-isobutyl-1-methylxanthine, 1 μM Dexamethasone, 850 nM Insulin, 1 nm Triiodothyronine, 125 nm Indomethacin and 1 μM Rosiglitazone for 2 days. Then, cells were changed to the complete medium supplemented with 1 nM T3, 850 nM Insulin, and 1 μM Rosiglitazone for another 2 days. Differentiated adipocytes at day 4 were maintained in complete medium until used for experiments. Representative immunoblots of NRP1 and EPHA7 in differentiated brown adipocytes transfected with si-Rbm3 or si-NC.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Carcinogenesis. 2023 May 27;44(3):242-251. [Abstract]

    Customer Validation
     Rosiglitazone (ROSI; 15, 30, 60, 120, 240 µM; 24 h) significantly inhibits the growth of NCI-H929 and OPM-2 cells.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Cell Metab. 2021 Mar 2;33(3):581-597.e9. [Abstract]

    Customer Validation
     Protein expression of PPRC1 and PPARG in HepG2 cells exposed to PA and treated with RGZ (Rosiglitazone) (30 mmol/L; 24 h), as analyzed by western blot.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     Protein levels of BACE1 and APP are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     Protein levels of sAPPα and sAPPβ are measured by western blot assay in cerebral cortex of 12-month-old AD mice with different treatments (RSG and GW9662).

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Eur J Pharmacol. 2019 Jan 15:843:134-144. [Abstract]

    Customer Validation
     PPARγ level is determined by IF assay in 3×Tg-AD mice, 3×Tg-AD mice with RSG treatment, 3×Tg-AD-KO mice, 3×Tg-AD-KO mice with GW9662 stimulation.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2018 Oct:126:259-268. [Abstract]

    Customer Validation
     Laser confocal microscope is performed to measure MMP indicated with the ratio of JC-1 Red/JC-1 Green. Nuclei are counterstained with DAPI (blue). Bar graphs represent the mean ± SD of red/green fluorescence intensity.

  • 1/16

    Rosiglitazone potassium purchased from MedChemExpress. Usage Cited in: Front Mol Neurosci. 2017 Sep 14:10:293. [Abstract]

    Customer Validation
     Rosiglitazone enhances the phosphorylation of insulin receptor substrate 1 (IRS1, phosphorylated at Ser 636/639), which is considered to be the main activator of the Akt/mTOR pathway by IGF-1R.

  • Rosiglitazone potassium